Registered entities
METAGENOMI.CO
Reg. No. 813909017United States
Metagenomi, Inc.
Reg. No. 32091010093United States
Innovation
58 patent families (12 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 1,657 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 5 |
| 2022 | 10 |
| 2023 | 31 |
| 2024 | 44 |
| 2025 | 41 |
| 2026 | 13 |
Social engagement
Social engagement: 16.5K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
24 investors on record; lead investors include RA Capital Management, Bayer, Humboldt Fund, Novo Holdings.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 12 | 50% |
| Private equity | 2 | 8% |
| Bank & private debt | 1 | 4% |
| Other / undisclosed | 9 | 38% |
Recent activity
28 May 2026
Event
Jefferies Global Healthcare Conference
11 May 2026
Event
Advancing the Next Generation of Tools for Precision Editing In Vivo
12 Mar 2026
Event
Keystone Symposia Conference on Precision Genome Engineering: From Basic Mechanisms to Application